ArticleHaematologica2023

Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation.

Tomoya Muto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.